Dr. Brigitte A. Semexant, DO

Dr. Semexant practices at Brigitte A. Semexant D.O. P.A. in Pembroke Pines, Florida.

Dr. Semexant's NPI, 1679556328, was assigned on November 28, 2005. Dr. Semexant graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1999. Dr. Semexant holds Florida license OS8548.

Dr. Semexant's primary practice is Brigitte A. Semexant D.O. P.A., at 10041 Pines Blvd, Pembroke Pines, FL 33024 in Broward County. The practice phone is (954) 965-1119.

Dr. Semexant's primary practice is Brigitte A. Semexant D.O. P.A. in Pembroke Pines, Florida. Dr. Semexant is also affiliated with Memorial Hospital West. Dmand AI also links Dr. Semexant to 3 more hospitals, 2 physician offices and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Semexant practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Semexant's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Semexant is board certified in 2001 - 2026 by the FL State License. Dr. Semexant is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, arthritis, chronic diabetes, chronic hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and coronary artery disease among the conditions Dr. Semexant treats.

CMS data shows 283 Medicare services from Dr. Semexant across 5 procedure codes in 2024, for 96 Medicare patients. Medicare paid $19,769 for them. Every service was in an office.

CMS counts 96 Medicare patients who saw Dr. Semexant in 2024. The largest group is 75 to 84, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Semexant's median patient age at 56, with 72% women.

In 2024, Dr. Semexant wrote 2,691 Medicare Part D claims for 226 patients. 86% of them were for generic drugs. CMS names the drug for 2,099 of them, across 56 drugs with 11 or more claims each, at $196,131 in total drug cost. In 2023, CMS named 1,649 claims across 51 drugs.

Dr. Semexant accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 30 general payments to Dr. Semexant from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $197.

Dr. Semexant graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1999. Dr. Semexant is a member of AOA.

Dr. Semexant is in network with 9 carriers, including Aetna, Cigna and Highmark. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.